S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NKTR Nektar Therapeutics

1.395

-0.005 (-0.36%)

Last Updated: 09:10:59

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics News

Nektar Management to Present at Upcoming Investor Conferences
Thursday 30 May 2024 (6 days ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 28 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Nektar Therapeutics Reports First Quarter 2024 Financial Results
Thursday 9 May 2024 (4 weeks ago) • PR Newswire (US)

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Thursday 2 May 2024 (1 month ago) • PR Newswire (US)

More Nektar Therapeutics News Articles

Brookmount Explorations (PK)

CTR Investments and Cons... (CE)

MicroCloud Hologram

Clean Vision (QB)

Decentral Life (PK)

GNCC Capital (CE)

Golden Triangle Ventures (PK)

Virexit Technologies (PK)

Rennova Health (PK)

Code Green Apparel (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions